Simplex Trading’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$482 Buy
70
+63
+900% +$588 ﹤0.01% 8739
2025
Q4
$61 Buy
+7
New +$129 ﹤0.01% 8323
2025
Q2
Sell
-37
Closed -$1K 8808
2025
Q1
$1K Buy
+37
New +$1.37K ﹤0.01% 8180
2024
Q4
Sell
-67
Closed -$1K 8677
2024
Q3
$1K Hold
67
﹤0.01% 8165
2024
Q2
$2K Sell
67
-143
-68% -$7.07K ﹤0.01% 8247
2024
Q1
$11K Buy
210
+163
+347% +$11.5K ﹤0.01% 7529
2023
Q4
$3K Buy
+47
New +$3.36K ﹤0.01% 8064
2023
Q3
Sell
-403
Closed -$44K 8825
2023
Q2
$44K Sell
403
-84
-17% -$9.87K ﹤0.01% 5958
2023
Q1
$52K Buy
487
+74
+18% +$7.06K ﹤0.01% 5874
2022
Q4
$35K Buy
413
+73
+21% +$6.68K ﹤0.01% 6272
2022
Q3
$22K Buy
340
+37
+12% +$3.18K ﹤0.01% 7403
2022
Q2
$22K Sell
303
-357
-54% -$41.8K ﹤0.01% 7481
2022
Q1
$96K Buy
660
+623
+1,684% +$132K ﹤0.01% 6206
2021
Q4
$12K Sell
37
-186
-83% -$71.9K ﹤0.01% 8854
2021
Q3
$82K Hold
223
﹤0.01% 6894
2021
Q2
$78K Buy
223
+221
+11,050% +$85.7K ﹤0.01% 7074
2021
Q1
$60K Buy
+2
New +$823 ﹤0.01% 6382
2020
Q3
Hold
0
-$2K 7879
2020
Q2
Sell
-3
Closed -$2.17K 7234
2020
Q1
$114K Buy
+3
New +$1.46K ﹤0.01% 4218

Other funds holding CUE

Simplex Trading's CUE Position: Q1 2026 in Review

Simplex Trading reduced its Cue Biopharma (CUE) stake by 66% in Q1 2026, selling an estimated $522 and leaving 29 shares worth $201. The position accounts for ﹤0.01% of the portfolio, ranked #8836.

Simplex Trading first reported a position in CUE in Q1 2020 and has held it in 18 quarters since. The position peaked at $130K in Q4 2021. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Simplex Trading held 29 shares of Cue Biopharma worth $201 as of Q1 2026.
  • Simplex Trading sold 56 Cue Biopharma shares in Q1 2026, an estimated $522.
  • Cue Biopharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8836 holding.
  • Simplex Trading first reported a position in Cue Biopharma in Q1 2020 and has held it in 18 quarters since.
  • Simplex Trading's Cue Biopharma position peaked at $130K in Q4 2021.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.